A First-in-human Study of HCR-188 in Overweight or Obese Otherwise Healthy Volunteers Without Type 2 Diabetes

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 4, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Obesity and Overweight

Interventions

DRUG

HCR-188

Single (SAD cohorts) or multiple (MAD cohorts) subcutaneous injections

DRUG

Placebo

Single (SAD cohorts) or multiple (MAD cohorts) subcutaneous injections

Trial Locations (1)

RECRUITING

Investigative Site, Herston